Kearney, M., Franks, L., Lee, S., Tiersten, A., Makower, D. F., Cigler, T., Mundi, P., Chi, D.-C., Goel, A., Klein, P., Andreopoulou, E., Sparano, J., Trivedi, M., Accordino, M., Califano, A., Hershman, D. L., Silva, J., & Kalinsky, K. (2021). Phase I/II trial of ruxolitinib in combination with trastuzumab in metastatic HER2 positive breast cancer. Breast Cancer Research and Treatment, 189(1), 177–185. https://doi.org/10.1007/s10549-021-06306-4